The Associate Director or Director, Value and Access, Dupixent will be a key contributor to Sanofi’s flagship brand Dupixent with specific Value & Access responsibilities for Dupixent in the Respiratory and pipeline therapeutic areas. This position will support both the tactical and strategic components of the Dupixent Value and Access team. This position will maintain a high level of collaboration and integration with the Dupixent brand team, US Market Access Shared Services, Market Research, Regulatory, Medical, HEOR, Legal, Training and other departments as necessary. This role will have responsibility for developing value and access strategy and resources for US Account Management Teams, managing trade association meetings, payer media planning, as well as field pull-through tools. This role will also ensure integration of payer insights across the Dupixent franchise and with key stakeholders through close collaboration with both the Professional and Consumer Marketing teams.
This position is be based in Cambridge, MA and reports to the Senior Director, Value and Access (Dupixent). Remote location may be considered on an exceptional basis.
Specific responsibilities include:
Developing non-branded and branded payer promotional items
Developing and coordinating training efforts in support of payer facing teams working closely with Value and Access, Account Management, Training, and Brand team leadership
Coordinating and contributing to payer market research efforts as needed (eg, Market Access advisory boards, syndicated reports, in-depth interviews, etc)
Serving as a contact for Genzyme engagement with payer trade associations & conferences (AMCP, NAMCP, PCMA, etc.)
Promotional Review Board (PRB) champion for Dupixent Value and Access (ie, medical, legal, regulatory review process)
Updating payer support tactics, marketing programs and tools.
Providing analytical support around payer reports to capture trends around coverage, distribution, and OOP costs, Budget tracking
Flexibility to take on other responsibilities, as needed by the business over time
Managing creative agencies
Ensuring compliance with government regulations and company processes
Basic Qualifications:
BA, BS or equivalent required, MBA or other graduate degree preferred
5-7+ years of biopharmaceutical industry experience
3+ years of Market Access experience, such as Payer Marketing, Account Management, Contracting, Training
Experience with specialty product sales, marketing or payer marketing
Preferred Qualifications:
Strong understanding of and experience in marketing
Understanding and experience in different access and reimbursement models, including Part B, Part D and Medicaid
Experience in developing tools and tactics applicable to US payer markets
Strong sense of professionalism, accountability and urgency for defined areas of responsibility
Ability to communicate tactical direction and related concepts clearly, orally and in writing, across internal and external audiences (e.g., sales, marketing, advocacy)
Strong project management capabilities including time and events, scenario and contingency planning, and the ability to ensure on-time and on-budget delivery of outputs and deliverables
Ability to develop and implement tactical executions that have high impact (e.g., marketing materials, special programs, etc.)
Experience in Dermatology and/or Respiratory is a plus
Ability to work effectively and efficiently with the medical/legal/regulatory submission and approval process to ensure appropriate review and timely delivery of materials
Capacity to engage effectively with agencies in order to translate marketing objectives into actionable and innovative strategies and solutions
Reliable and responsible management of budgets and expenses
Strong communication skills
Ability to travel approximately 25%-50% post COVID
Proven ability to align internal stakeholders and achieve results through collaboration
Cambridge, MA
As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.
Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.
Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.
Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.